Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland
Authors/Creators
- 1. University Hospital of Geneva
Description
Objectives: To determine the proportion of patients who received a treatment for Clostridioides difficile infection (CDI) among those presenting a discordant Clostridioides difficile diagnostic assay and to identify patient characteristics associated with the decision to treat CDI.
Design: Cross-sectional study.
Setting: Monocentric study in a tertiary care hospital, Geneva, Switzerland
Participants: Among 4562 adult patients tested for C. difficile between March 2017 and March 2019, 208 patients with discordant tests' results (positive nucleic acid amplification test [NAAT+]/negative enzyme immunoassay [EIA-]) were included.
Main outcome measures: Treatment for CDI.
Results: CDI treatment was administered in 147 (71%) cases. In multivariate analysis, an abdominal computed tomography scan with signs of colitis (OR 14.7; 95% CI 1.96-110.8) was the only factor associated with CDI treatment.
Conclusions: The proportion of NAAT+/EIA- patients who received treatment questions the contribution of the EIA for the detection of toxin A/B after NAAT to limit overtreatment. Additional studies are needed to investigate if other factors are associated with the decision to treat.
Notes
Files
README.md
Files
(54.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:100e33f2f206a1364852ffa0a4cc218b
|
47.2 kB | Download |
|
md5:231b89ec9cdee9a8d399d9340fb0b3c9
|
7.0 kB | Preview Download |